5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid 2212021-83-3

5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid 2212021-83-3
Product Description

Orforglipron intermediates

EnBridge PharmTech (Wuxi) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    2212021-83-3
  • Details
     Orforglipron intermediates

  • Supplied from
    China
  • Measured In
    kilogram; kilojoule

EnBridge PharmTech (Wuxi) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer

More Products from EnBridge PharmTech (Wuxi) Co., Ltd. (24)